Expert Ratings for Johnson & Johnson
Portfolio Pulse from Benzinga Insights
Johnson & Johnson (NYSE:JNJ) has received various analyst ratings in the last quarter, with 2 bullish, 2 somewhat bullish, and 3 indifferent. The average 12-month price target for JNJ, according to 7 analysts, is $165.43, a 10.14% increase from the previous average of $150.20.
July 13, 2023 | 6:01 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Johnson & Johnson has received mixed analyst ratings, with an average 12-month price target of $165.43, indicating a potential upside.
The mixed analyst ratings indicate uncertainty about the company's performance. However, the increased average price target suggests that analysts see potential for growth, which could positively impact the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100